Stock Details
MDT is Medtronic plc's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 82.59$. Average daily volumn in 3 months 6.91M. Market cap 105.41B



Stock symbol : MDT. Exchange : NYSE. Currency : USD
Lastest price : 79.25$. Total volume : 7.12M. Market state PREPRE
Click reload if you want to check the lastest price on market!!!

Medtronic plc (MDT)
Last Price
79.25$
Change
0.21
Volume
7.12M

Previous Close79.04
Open79.31
Day Range78.92-80.15
Bid0.00 x 1k
Ask0.00 x 800
Volume7.12M
Average Volume6.91M
Market Cap105.41B
Beta0.78
52 Week Range75.83-114.44
Trailing P/E24.61
Foward P/E14.62
Dividend (Yield %)3.56%
Ex-Dividend Date2022-09-22



Financial Details


According to Medtronic plc's financial reports the company's revenue in 2022 were 31.69B an increase( +3.33%) over the years 2021 revenue that were of 30.12B. In 2022 the company's total earnings were 5.04B while total earnings in 2021 were 3.61B( +66.67%).


Loading ...



Organization

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repa... ir products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Market Cap:
105.41B
Revenue:
31.69B
Total Assets:
90.98B
Total Cash:
3.71B



News about "Medtronic plc"

A Look At The Intrinsic Value Of Medtronic plc (NYSE:MDT)

Source from : YAHOO!Finance - 1 days ago

Today we will run through one way of estimating the intrinsic value of Medtronic plc ( NYSE:MDT ) by estimating ...See details»


Medtronic slumps as annual outlook hurt by forex, slow recovery

Source from : Reuters - 10 days ago

Nov 22 (Reuters) - Medtronic Plc (MDT.N) on Tuesday lowered its full-year outlook for profit and revenue growth, blaming a stronger dollar and a slower-than-anticipated recovery in supply chain ...See details»


Medtronic plc (MDT) Q2 2023 Earnings Call Transcript

Source from : Seeking Alpha - 9 days ago

Good morning. I am Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations and welcome to snowing Minneapolis. I appreciate that you are joining us today for Medtronicโ€™s ...See details»


medtronic-mdt-q2-earnings-beat-estimates-margins-down-image

Medtronic (MDT) Q2 Earnings Beat Estimates, Margins Down

Source from : Zacks.com on MSN - 9 days ago

Medtronic plc MDT reported adjusted earnings per share (EPS) of $1.30 in second-quarter fiscal 2023, beating the Zacks Consensus Estimate by 1.6%. However, adjusted earnings declined 1.5% from the ...See details»


Share Price

Source from : Forbes - 9 days ago

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the ...See details»


With 84% ownership, Medtronic plc (NYSE:MDT) boasts of strong institutional backing

Source from : Yahoo News - 12 days ago

Every investor in Medtronic plc (NYSE:MDT) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are institutions with 84% ownership. Put ...See details»


Medtronic plc 2023 Q2 - Results - Earnings Call Presentation

Source from : Seeking Alpha - 9 days ago

Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site ...See details»


Medtronic Trims FY23 Annual Outlook On Currency Headwind, Posts Mixed Q2 Earnings

Source from : AOL - 9 days ago

Medtronic Plc's (NYSE: MDT) Q2 FY23 sales of $7.58 billion decreased 3% Y/Y on a reported basis and increased 2% organically, missing the consensus of $7.70 billion.See details»


What's in the Cards for Medtronic (MDT) in Q2 Earnings?

Source from : AOL - 13 days ago

Medtronic plc MDT is scheduled to report second-quarter and fiscal 2023 results on Nov 22, before the opening bell. In the last reported quarter, the companyโ€™s earnings lagged the Zacks ...See details»


Medtronic Cuts Full-Year Earnings, Organic Revenue Guidance

Source from : MarketWatch - 10 days ago

Medtronic PLC cut its guidance for organic revenue and full-year adjusted earnings, and said the strong U.S. dollar will take a bigger bite out of revenue growth than previously expected.See details»


Deadline Alert: Medtronic plc (MDT) Class Action - Bronstein, Gewirtz & Grossman, LLC, A Prominent Firm, Reminds Shareholders of Last Few Hours to Actively Participate

Source from : newsroom.businesswire.com - 25 days ago

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Medtronic plc (โ€œMedtronicโ€ or the ...See details»


Medtronic Plc

Source from : U.S. News & World Report - 9 days ago

Financial advisors can help their clients by planning ahead and taking advantage of the higher retirement contribution limits in 2023.See details»


Medtronic cuts annual profit forecast blaming strong dollar

Source from : Yahoo - 10 days ago

The medical device maker now sees its adjusted profit in the range of $5.25 to $5.30 per share in fiscal 2023, compared with $5.53 to $5.65 it previously expected. "Slower-than-predicted procedure and ...See details»


Thinking Of Selling Medtronic plc (NYSE: MDT) Stock? Read This First.

Source from : stocksregister - 13 days ago

Medtronic plc (NYSE:MDT) shares, rose in value on Friday, November 18, with the stock price up by 0.85% to the previous dayโ€™s close as strong demand from buyers drove the stock to $80.62. Actively ...See details»